Want to see PRCT full AI Analyst Report?
Revenue by Segment
Separates income from capital device sales, consumable disposables, and recurring services or training, showing how much revenue is one-time versus repeatable. A higher share of consumables and service revenue points to more predictable, annuity-like cash flow from the installed base, while heavy reliance on device sales makes results more dependent on hospital budgets and adoption cycles.Consumables (handpieces) have become the revenue engine—now the largest, recurring, and fastest-growing line, reflecting accelerating procedures and strong customer stickiness—critical for predictable lifetime revenue. System sales remain lumpy but rising ASPs show pricing power and uptake among larger accounts; however system variability plus management’s commercial realignment and higher tariffs create back‑loaded benefits and margin risk. Watch Q2 procedure momentum, the handpiece:procedure ratio and sustained system ASPs—those will determine whether gross‑margin targets and the promised Q4 EBITDA inflection are achievable.
Date | Service | System Sales and Leases | Handpieces and Other Consumables |
|---|---|---|---|
Jun 30, 2026 | $6.84M | $32.47M | $55.20M |
Mar 31, 2026 | $6.50M | $27.24M | $49.39M |
Dec 31, 2025 | $5.85M | $30.55M | $39.98M |
Sep 30, 2025 | $5.46M | $28.14M | $49.73M |
Jun 30, 2025 | $5.02M | $25.03M | $49.13M |
Mar 31, 2025 | $4.13M | $22.54M | $42.49M |
Dec 31, 2024 | $3.88M | $30.63M | $33.73M |
Sep 30, 2024 | $3.34M | $22.80M | $32.24M |
Jun 30, 2024 | $2.92M | $20.90M | $29.53M |
Mar 31, 2024 | $2.60M | $15.98M | $25.96M |